Bu Shen Yang Xue Prescription Has Treating Effect on Endometrial Cancer through FSH/PI3K/AKT/Gankyrin/HIF-α/cyclinD 1 Pathway in Ishikawa Cells

Background. The formulation of Bu Shen Yang Xue (BSYX) has been clinically used in treating gynecologic disease in China, especially for the development of the endometrium. Endometrial carcinoma is the most common malignant tumor of the female genital tract in developed countries. And few studies ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yue-qun, Fei, Hua-li, Zhu, Hong-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198581/
https://www.ncbi.nlm.nih.gov/pubmed/30402135
http://dx.doi.org/10.1155/2018/8412984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198581/
https://www.ncbi.nlm.nih.gov/pubmed/30402135
http://dx.doi.org/10.1155/2018/8412984

Ejemplares similares